JAGX Financials

Jaguar Health Inc - Financial statements & key metrics

Stock Price

$0.42

Market Cap

$5.58M

0

EPS

$-22.97

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$11.69M

Gross Profit

-

Operating Income

-

Net Income

$-39.25M

EPS (Diluted)

$-130.69

Balance Sheet Highlights

Total Assets

$53.42M

Total Liabilities

$44.45M

Shareholders Equity

-

Cash & Equivalents

$8.00M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-29.38M

CapEx

-

Free Cash Flow

-

Profitability Metrics

Gross Margin

67.2%

Operating Margin

-6.3%

ROE

-4.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is JAGX revenue?

JAGX's most recent quarterly revenue was $11.69M. Annual revenue can be calculated by summing the four most recent quarters.

Is JAGX profitable?

JAGX reported a loss of $39.25M in the most recent quarter.

What is JAGX market cap?

JAGX has a market capitalization of $5.58M, making it a small-cap stock.

Does JAGX have debt?

View JAGX's balance sheet for debt information.

What is JAGX cash flow?

Cash flow data is available in the full financial statements.

Explore Categories